ARG1 and central nervous system cancer: In the context of a high-grade brain tumor model where glioma-associated macrophages/microglia (GAMs) were M2 polarized, CSF1R inhibitors were found to decrease expression of M2 markers in GAMs such as Arg1 and Mrc1 (CD206) without influencing their numbers [17, 18].